News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Rick McKellar, BS

Articles by Rick McKellar, BS

Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes

ByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MA

July 2nd 2013

Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes

ByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MA

February 12th 2013

Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.

Latest Updated Articles

Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
February 12th 2013
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
July 2nd 2013

Trending on AJMC

Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD

Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD

60% of US Women Face Barriers to Postpartum, Mental Health Care

Counseling Vitiligo Patients on Time to Repigmentation

5 August FDA Approvals Marked by Novelty, Pushback